(24/7 MARKET NEWS) – Ardelyx, Inc. (Nasdaq: ARDX) reported, after yesterday’s market close, its fourth quarter and full year ended December 31, 2022 financial results and provided a business update. Highlights included that its April 2022 launch of IBSRELA resulted in $15.6 million in net product sales and that the Company ended the year with approximately $123.9 million in cash and investments.
Also yesterday, Wedbush upgrades Ardelyx to Outperform and raised its price target to $6.
Ardelyx is at $3.3315, up $0.4415 (+15.28%), on 2.5 million premarket shares.
Its 52-week trading range is $0.4902 to $3.43. If it can break through the 52-week high of $3.43, on strong trading volume, it should fill in the gap to the $6 price target.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.
Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.
